Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Medical Genetics

The Types of Galactosemia & Genetics

At a Glance

Galactosemia is an inherited condition where the body cannot break down milk sugar. Classic Galactosemia is the most severe and requires a strict lactose-free diet. Doctors use genetic testing to distinguish it from milder forms, like the Duarte variant, which often need no treatment.

Understanding your child’s diagnosis starts with understanding the Leloir pathway—the body’s “assembly line” for processing sugar [1]. Imagine a factory line where four workers (enzymes) take a raw material called galactose (from milk) and turn it into a finished product called glucose (energy) [1][2].

The Four “Workers” (Enzymes)

When one of these workers is missing or unable to do their job, the line stops, and unfinished materials (toxins) build up. The type of galactosemia your child has depends on which worker is affected [3][1]:

  1. Type I: Classic Galactosemia (GALT). This is the most common and serious form. The GALT enzyme is the main worker [1][2]. If GALT is missing, a toxic byproduct called galactose-1-phosphate builds up quickly, which can damage the liver and brain [4][5].
  2. Type II: Galactokinase Deficiency (GALK). The GALK worker is missing. The main risk here is the development of cataracts (clouding of the eye lens) because the unprocessed sugar moves into the eyes [1][6].
  3. Type III: Epimerase Deficiency (GALE). The GALE worker is affected. This type ranges from very mild (only affecting blood cells) to severe (similar to Classic) [1][7].
  4. Type IV: GALM Deficiency. This is a recently discovered form where the GALM worker—who “shapes” the sugar so other workers can grab it—is missing [3][8].

The GALT Gene and Recurrence Risks

Your child’s “instruction manual” for building these workers is their DNA. The GALT gene provides the instructions for the Type I worker [9]. Mutations are like “typos” in that manual.

Galactosemia is an autosomal recessive condition [1]. This means a child must inherit two mutated copies of the gene (one from each parent) to have the disease. Because both parents are carriers, there is a 25% chance with each future pregnancy that the child will have Galactosemia [10]. Genetic counseling is highly recommended to discuss family planning and testing options.

Classic vs. Duarte: A Critical Difference

Newborn screens frequently flag the Duarte variant (caused by a milder mutation called N314D), which is much less severe than Classic Galactosemia (often caused by the Q188R mutation) [11][12]. Distinguishing between them is vital because the required treatment is completely different [11][13].

Feature Classic Galactosemia Duarte Variant
Enzyme Activity 0% to <5% [14] Roughly 25% to 50% [11]
Risk of Symptoms High risk of liver/brain issues [4] Generally no increased risk [11]
Dietary Treatment Strict lifelong lactose-free diet [15] Often no diet or restriction needed [11]
Breastfeeding Not allowed (must use soy) [10] Usually allowed and safe [11]

How Doctors Confirm the Type

To move from a “positive screen” to a “confirmed type,” doctors use two main tools:

  • Quantitative Enzyme Assay: This measures exactly how fast the “worker” is moving in a blood sample. It tells doctors the percentage of enzyme activity [13][16].
  • Molecular Genetic Testing: This reads the GALT gene “instruction manual” word-for-word to find the exact mutations [9][17]. This confirms if your child is a homozygote (two identical severe typos) or a compound heterozygote (one severe and one mild typo) [17][18].

Common questions in this guide

What is the difference between Classic Galactosemia and the Duarte variant?
Classic Galactosemia is a severe form requiring a strict lifelong lactose-free diet to prevent liver and brain damage. The Duarte variant is much milder, often requires no dietary restrictions, and breastfeeding is typically safe.
How do doctors determine which type of galactosemia my child has?
Doctors use a quantitative enzyme assay to measure enzyme activity levels in the blood. They also use molecular genetic testing to identify the exact mutations in the GALT gene to confirm the specific type and severity.
How is galactosemia inherited?
Galactosemia is an autosomal recessive condition, meaning a child must inherit a mutated gene from both parents. If both parents are carriers, there is a 25 percent chance with each pregnancy that the child will have the condition.
What happens if a child has Type 2 galactosemia?
In Type 2 galactosemia, or GALK deficiency, the primary risk is the development of cataracts. This occurs because the unprocessed sugar moves into the lenses of the eyes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my child's exact percentage of GALT enzyme activity?
  2. 2.Does my child have the Classic (G/G) genotype, the Duarte (D/G) genotype, or another specific combination?
  3. 3.Based on these specific results, is a restricted diet medically necessary, or can we safely resume breastfeeding?
  4. 4.If my child has Type II (GALK) or Type III (GALE), how does the long-term monitoring differ from Type I?
  5. 5.Can you provide a referral to a genetic counselor to discuss future family planning?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

    Treacy EP, Vencken S, Bosch AM, et al.

    JIMD reports 2021; (61(1)):76-88 doi:10.1002/jmd2.12237.

    PMID: 34485021
  2. 2

    Effect of genotype on galactose-1-phosphate in classic galactosemia patients.

    Yuzyuk T, Balakrishnan B, Schwarz EL, et al.

    Molecular genetics and metabolism 2018; (125(3)):258-265 doi:10.1016/j.ymgme.2018.08.012.

    PMID: 30172461
  3. 3

    The structural and molecular biology of type IV galactosemia.

    Banford S, Timson DJ

    Biochimie 2021; (183()):13-17 doi:10.1016/j.biochi.2020.11.001.

    PMID: 33181226
  4. 4

    Transient Cytopenias as a Rare Presentation of Classic Galactosemia.

    Gianniki M, Nikaina I, Avgerinou G, et al.

    Cureus 2022; (14(3)):e23101 doi:10.7759/cureus.23101.

    PMID: 35464534
  5. 5

    Galactose-1-phosphate inhibits cytochrome c oxidase and causes mitochondrial dysfunction in classic galactosemia.

    Machado CM, de-Souza-Ferreira E, Silva GFS, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2024; (1870(7)):167340 doi:10.1016/j.bbadis.2024.167340.

    PMID: 38986816
  6. 6

    Recommendations for newborn screening for galactokinase deficiency: A systematic review and evaluation of Dutch newborn screening data.

    Stroek K, Bouva MJ, Schielen PCJI, et al.

    Molecular genetics and metabolism 2018; (124(1)):50-56 doi:10.1016/j.ymgme.2018.03.008.

    PMID: 29580649
  7. 7

    A Case of UDP-Galactose 4'-Epimerase Deficiency Associated with Dyshematopoiesis and Atrioventricular Valve Malformations: An Exceptional Clinical Phenotype Explained by Altered N-Glycosylation with Relative Preservation of the Leloir Pathway.

    Febres-Aldana CA, Pelaez L, Wright MS, et al.

    Molecular syndromology 2020; (11(5-6)):320-329 doi:10.1159/000511343.

    PMID: 33510604
  8. 8

    Biallelic GALM pathogenic variants cause a novel type of galactosemia.

    Wada Y, Kikuchi A, Arai-Ichinoi N, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(6)):1286-1294 doi:10.1038/s41436-018-0340-x.

    PMID: 30451973
  9. 9

    A case report of classic galactosemia with a GALT gene variant and a literature review.

    Wang YC, Lan LC, Yang X, et al.

    BMC pediatrics 2024; (24(1)):352 doi:10.1186/s12887-024-04769-0.

    PMID: 38778342
  10. 10

    Galactosemia.

    Cerone J, Rios A

    Pediatrics in review 2019; (40(Suppl 1)):24-27 doi:10.1542/pir.2018-0150.

    PMID: 31575690
  11. 11

    Answering a Question Older Than Most Pediatricians: What to Do About Duarte Variant Galactosemia.

    McCandless SE

    Pediatrics 2019; (143(1)) doi:10.1542/peds.2018-3292.

    PMID: 30593448
  12. 12

    Mutational analysis of GALT gene in Greek patients with galactosaemia: identification of two novel mutations and clinical evaluation.

    Schulpis KH, Thodi G, Iakovou K, et al.

    Scandinavian journal of clinical and laboratory investigation 2017; (77(6)):423-427 doi:10.1080/00365513.2017.1334262.

    PMID: 28644047
  13. 13

    Addition of galactose-1-phosphate measurement enhances newborn screening for classical galactosemia.

    Daas S, Abu Salah N, Anikster Y, et al.

    Journal of inherited metabolic disease 2023; (46(2)):232-242 doi:10.1002/jimd.12580.

    PMID: 36515074
  14. 14

    Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia.

    Haskovic M, Derks B, van der Ploeg L, et al.

    Orphanet journal of rare diseases 2018; (13(1)):212 doi:10.1186/s13023-018-0954-8.

    PMID: 30477550
  15. 15

    The Importance of Neonatal Screening for Galactosemia.

    Badiu Tișa I, Achim AC, Cozma-Petruț A

    Nutrients 2022; (15(1)) doi:10.3390/nu15010010.

    PMID: 36615667
  16. 16

    Including Classical Galactosaemia in the Expanded Newborn Screening Panel Using Tandem Mass Spectrometry for Galactose-1-Phosphate.

    Cohen AS, Baurek M, Lund AM, et al.

    International journal of neonatal screening 2019; (5(2)):19 doi:10.3390/ijns5020019.

    PMID: 33072978
  17. 17

    Classic Galactosemia: Clinical and Computational Characterization of a Novel GALT Missense Variant (p.A303D) and a Literature Review.

    Forte G, Buonadonna AL, Pantaleo A, et al.

    International journal of molecular sciences 2023; (24(24)) doi:10.3390/ijms242417388.

    PMID: 38139222
  18. 18

    Molecular characterization of novel and rare DNA variants in patients with galactosemia.

    Maroulis V, Agathangelidis A, Skouma A, et al.

    Frontiers in genetics 2023; (14()):1266353 doi:10.3389/fgene.2023.1266353.

    PMID: 38090149

This page provides educational information about galactosemia types and genetics. It does not replace professional medical advice, diagnosis, or treatment planning from your child's pediatrician or pediatric geneticist.

Get notified when new evidence is published on Galactosemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.